ABSTRACT
Peritonitis is a frequent complication in patients with chronic renal failure on continuous ambulatory peritoneal dialysis (CAPD) treatment. The aim of this study was to know the prevalence of fungal peritonitis on patients undergoing CAPD, and to determine the antifungal susceptibility pattern of the identified isolates. Samples of the peritoneal dialysis fluid from 165 patients on CAPD treatment with peritonitis manifestations were submitted to mycological study (direct microscopic examination, culture and antifungal susceptibility test). Ten Candida isolates were identified, being C. albicans and C. parapsilosis the most common species. From isolates obtained, three species (C. albicans, C. parapsilosis, and C. guilliermondii) presented itraconazole resistance while C. glabrata was resistant to both itraconazole and ketoconazole. Aspergillus fumigatus was associated to peritonitis in three cases and Acremonium sp. in two.
Subject(s)
Mycoses/microbiology , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/microbiology , Acremonium/drug effects , Acremonium/isolation & purification , Aged , Antifungal Agents/pharmacology , Aspergillus/drug effects , Aspergillus/isolation & purification , Candida/drug effects , Candida/isolation & purification , Child , Drug Resistance, Fungal , Female , Fluconazole/pharmacology , Humans , Itraconazole/pharmacology , Ketoconazole/pharmacology , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/therapy , Male , Mexico , Microbial Sensitivity Tests , Middle Aged , Mycoses/drug therapy , Peritonitis/drug therapyABSTRACT
Nosocomial yeast infections have become a major cause of morbidity and mortality in immunocompromised patients. This study presents the frequency of yeasts isolated from different biological products from a Mexico City hospital's patients during one year. C. albicans was isolated in 72.3% of patients, followed by C. glabrata (13.4%) and C. parapsilosis (8%). Twenty different morphotypes were identified and the serotype B was the most frequent (79%).
Subject(s)
Candidiasis/microbiology , Cross Infection/microbiology , Candida/classification , Female , Hospitalization , Humans , Male , Mexico , SerotypingABSTRACT
Nosocomial yeast infections have become a major cause of morbidity and mortality in immunocompromised patients. This study presents the frequency of yeasts isolated from different biological products from a Mexico City hospital's patients during one year. C. albicans was isolated in 72.3 of patients, followed by C. glabrata (13.4) and C. parapsilosis (8). Twenty different morphotypes were identified and the serotype B was the most frequent (79).
Subject(s)
Humans , Male , Female , Candidiasis/microbiology , Cross Infection/microbiology , Candida , Hospitalization , Mexico , SerotypingABSTRACT
Nosocomial yeast infections have become a major cause of morbidity and mortality in immunocompromised patients. This study presents the frequency of yeasts isolated from different biological products from a Mexico City hospitals patients during one year. C. albicans was isolated in 72.3 of patients, followed by C. glabrata (13.4) and C. parapsilosis (8). Twenty different morphotypes were identified and the serotype B was the most frequent (79).(AU)
Subject(s)
Humans , Male , Female , Candidiasis/microbiology , Cross Infection/microbiology , Candida/classification , Hospitalization , Mexico , SerotypingABSTRACT
Nosocomial yeast infections have become a major cause of morbidity and mortality in immunocompromised patients. This study presents the frequency of yeasts isolated from different biological products from a Mexico City hospitals patients during one year. C. albicans was isolated in 72.3
of patients, followed by C. glabrata (13.4
) and C. parapsilosis (8
). Twenty different morphotypes were identified and the serotype B was the most frequent (79
).
